ODL to Showcase Large Format Blink Blinds + Glass at IBS 2022

2022-06-03 21:25:29 By : Ms. Erin Tan

Available Up to 8’x8’, Blink Lets the Outside into the Home While Delivering Maximum Privacy

ZEELAND, Mich., February 07, 2022--(BUSINESS WIRE)--ODL, Inc., a leader in the building products industry with an emphasis in fenestration, will introduce Large Format Blink® Blinds + Glass available up to a vast 8’x8’ at the 2022 International Builders’ Show (Booth W4021, West Hall). With the new, oversized options, the popular Blink line, featuring durable blinds sandwiched between two panes of glass, will appeal to a wider audience of homeowners and architects designing residential or light commercial structures.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220207005105/en/

Large Format Blink® Blinds + Glass (Photo: Business Wire)

The new large format is designed for massive picture windows, large bath windows, and expansive sliding and multi-panel sliding patio doors. These Blink options are an ideal fit for designs maximizing natural light and outdoor views, yet also capable of shutting out the outside world and delivering complete privacy.

Matching components in six colors

Available in tempered or annealed glass

Available in single- or dual-operator design

Custom sizes of 8"-63" wide x 30"-90" tall

9 different Low-E coatings for to minimize the amount ultraviolet and infrared light that enters the home

EasyGlide Operator raises, lowers, and tilts blinds with just slight movement, reducing operating effort by 30%

"Creation of Blink blinds at this scale required substantial investment in new designs, materials, and engineering," said Dan Bennett, Senior Product Manager, Light and Privacy at ODL, Inc. "The resulting opportunities for these massive Blink products will satisfy a growing trend for applications that maximize views and natural light, while simultaneously providing absolute privacy."

Large format Blink Blinds + Glass will be on display Feb. 8-10, 2022, at IBS in the ODL, Inc. booth, W4021. For more information about ODL’s Blink Blinds + Glass, visit: https://www.odl.com/blink

ODL, Inc. was founded in 1945 and corporate headquarters are located in Zeeland, Michigan. Over 75 years later, the company offers products designed to build value into the home under the following brands: ODL, Blink Blinds + Glass, Western Reflections and Kenyon’s Glass. Product offerings include decorative and clear doorglass; enclosed blinds; custom decorative glass for windows, doors and transoms; and doorglass frames. ODL products are sold through building material dealers and home center retailers nationwide.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220207005105/en/

Devon Prince dprince@purdierogers.com 360-567-7341

(Bloomberg) -- Novavax Inc. slumped 20% on Friday after US regulators raised concerns over the biotech’s much-anticipated Covid-19 vaccine. Most Read from BloombergOne-Third of Americans Making $250,000 Live Paycheck-to-Paycheck, Survey FindsTesla Pauses Hiring as Musk Aims for 10% Staff Cut, Reuters SaysElon Musk’s Ultimatum to Tesla Execs: Return to the Office or Get Out‘Most Clever Oligarch’ Severed His $37 Billion Fortune From Russian RootsApple Plans to Make the iPad More Like a Laptop and

The FDA suggested Friday there could be a link between Novavax's Covid vaccine and heart inflammation, and NVAX stock plummeted.

These big names are down — but certainly not out.

In the world of stock legends, Ken Fisher stands out. The legendary investor founded his private financial advisory firm, Fisher Investments, in 1979, with just $250 in seed money. Today, Fisher’s company manages over $195 billion in total assets, and his personal net work exceeds $5 billion. Fisher has cast his eye on current market conditions. In recent published note, Fisher points out the obvious headwinds in the current environment: “Fear of the impact of the tragic, grinding war in Ukraine

U.S. Food and Drug Administration staff said on Friday Novavax Inc's vaccine reduces the risk of mild-to-severe COVID-19 and that it was likely the shot could provide some level of protection against the Omicron variant. The FDA analyzed data from Novavax's trial before the Omicron and Delta variant became the dominant strains. "Based on the efficacy estimate in the clinical trial of this vaccine, it is more likely than not that the vaccine will provide some meaningful level of protection against COVID-19 due to Omicron, in particular against more severe disease," FDA staff said.

U.S. Labor Secretary Marty Walsh says it's time for his new billionaire acquaintance Elon Musk to give him another phone call as the Tesla CEO eyes mass layoffs at the EV maker.

Semiconductor specialist Nvidia (NASDAQ: NVDA) was down as much as 5.5%, iPhone maker Apple (NASDAQ: AAPL) was off by as much as 4.5%, and e-commerce kingpin Amazon (NASDAQ: AMZN) slipped as much as 3.5%. New warnings about the possibility of a recession sent a wide swath of stocks lower today, but there was also company-specific news for each of the technology stalwarts. Tesla CEO Elon Musk joined the chorus of business leaders sounding the alarm about the economy and the possibility of a recession.

Piper Sandler is scared of a computer memory glut, but Micron's stock price is cheap enough to already factor that in.

Don’t bail on stocks. Just choose them wisely.

One of the proposed shareholder measures, which was expected to be rubber-stamped by investors, has hit some surprising resistance.

(Bloomberg) -- Mark Spitznagel is paid to be prepared for when the market’s weakest links are exposed in a big way.Most Read from BloombergOne-Third of Americans Making $250,000 Live Paycheck-to-Paycheck, Survey FindsTesla Pauses Hiring as Musk Aims for 10% Staff Cut, Reuters SaysElon Musk’s Ultimatum to Tesla Execs: Return to the Office or Get Out‘Most Clever Oligarch’ Severed His $37 Billion Fortune From Russian RootsApple Plans to Make the iPad More Like a Laptop and Less Like a PhoneRight no

Elon Musk stole the spotlight this morning, and his reported comments are hitting the stock prices of many electric vehicle (EV) makers. Nio (NYSE: NIO) is one that shares the Chinese market with Musk's Tesla, and its American depositary shares are being impacted. As of 11:06 a.m. ET, Nio shares were down 4.9% on the final trading day of the week.

Tesla CEO Elon Musk's "super bad feeling" about the economy could be the auto industry's "canary in the coal mine" moment, signaling a recession for an industry whose bosses have shown no signs of concern. Musk said the electric carmaker needed to cut about 10% of its workforce in an email to executives seen by Reuters. Musk's warning is the first loud and public dissent in a united stance by the auto industry that underlying demand for cars and trucks remains strong despite two years of global pandemic.

(Bloomberg) -- China has sentenced a former Communist Party city chief and securities regulator to death with a two-year reprieve for bribery and insider trading, state broadcaster CCTV reported.Most Read from BloombergOne-Third of Americans Making $250,000 Live Paycheck-to-Paycheck, Survey FindsTesla Pauses Hiring as Musk Aims for 10% Staff Cut, Reuters SaysElon Musk’s Ultimatum to Tesla Execs: Return to the Office or Get OutApple Plans to Make the iPad More Like a Laptop and Less Like a PhoneU

Yahoo Finance Live anchors discuss Sycamore and Franchise Group becoming the latest to submit bids for Kohl’s.

For several months now, relations between the Democratic Party president and the tech tycoon have been at their worst. The bone of contention: Tesla's chief executive blames the Biden administration for ignoring Tesla as it celebrates the auto industry's transformation to electric vehicles. Musk does not understand why Biden puts forward GM , Ford and others in this transformation and forgets Tesla, which is by far the world's leading EV manufacturer.

Amazon stock is working on its sixth straight daily rally ahead of its 20-for-1 stock split. Here's what the charts say now.

Novavax Inc.’s (NASDAQ: NVAX) stock tanked more than 20% Friday afternoon after the Food and Drug Administration shared concerns about a potential connection between heart inflammation and the company’s experimental Covid-19 vaccine, which the agency expects to take into consideration next week for potential emergency use authorization. As part of a briefing released Friday, the FDA said its vaccines advisory committee will meet Tuesday to discuss the Gaithersburg company's submission and “provide recommendations on whether, based on the totality of scientific evidence available, the benefits of the Novavax Covid-19 Vaccine 2-dose primary series outweigh its risks for use in individuals 18 years of age and older.” The risks, according to the documents, namely include the potential for inflammation in and around the heart, known as myocarditis and pericarditis.

U.S. stocks dropped Friday as investors weighed hot May jobs data that likely gave a nod to Fed policymakers labor market conditions could weather a more aggressive rate hiking cycle.

Median student-loan debts last year were $20,000 to $24,999, according to one Federal Reserve survey.